Impact of mepolizumab in patients with high-burden severe asthma within a managed care population. Lugogo NL, Bogart M, Corbridge T, Packnett ER, et al. J Asthma 2022 Jul 19:1-16. doi: 10.1080/02770903.2022.2102036.

Read + Share

Amedeo Smart

Independent Medical Education

Lugogo NL, Bogart M, Corbridge T, Packnett ER, et al. Impact of mepolizumab in patients with high-burden severe asthma within a managed care population. J Asthma 2022 Jul 19:1-16. doi: 10.1080/02770903.2022.2102036.
PMID: 35853158